Immunodeficiency Syndromes

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-05-28
EMA Authorised: Privigen (human normal immunoglobulin (IVIg)) — CSL Behring GmbH
Privigen (human normal immunoglobulin IVIg) has been authorised by the EMA for multiple indications. The listed therapeutic areas include id…